Medicines

Here you will find the recommendations we have made about the use of individual medicines in Lancashire.

Empagliflozin

Brand:  Jardiance®
NICE TA: 390
Indication: Monotherapy for treating type 2 diabetes (NICE TA390)
Disease category: Endocrine system
Commissioning responsibility: CCG
PbR excluded: No

Background

Canagliflozin, dapagliflozin and empagliflozin as monotherapies are recommended as options for treating type 2 diabetes in adults for whom metformin is contraindicated or not tolerated and when diet and exercise alone do not provide adequate glycaemic control, only if:
• a dipeptidyl peptidase‑4 (DPP‑4) inhibitor would otherwise be prescribed and
• a sulfonylurea or pioglitazone is not appropriate.
The LMMG recommends empagliflozin as a 1st line ““gliflozin””.

Decisions of Lancashire local decision making groups:

NHS Blackburn With Darwen CCG and NHS East Lancashire CCG NHS Blackpool CCG NHS Chorley and South Ribble CCG and NHS Greater Preston CCG NHS Fylde and Wyre CCG NHS Morecambe Bay CCG NHS West Lancashire CCG

Green

Green

Green

Green

Green

Green